Curated News
By: NewsRamp Editorial Staff
October 16, 2024
SANUWAVE Health, Inc. Announces Implementation of 1-for-375 Reverse Stock Split
Discuss on Reddit
Discuss on SubstackTLDR
- SANUWAVE Health, Inc. will implement a 1-for-375 reverse stock split, reducing outstanding shares and potentially increasing stock value.
- The reverse stock split will combine 375 shares into one, with proportional adjustments to outstanding equity awards and warrants.
- SANUWAVE Health's focus on regenerative medicine products helps restore the body’s normal healing processes, benefiting patients and healthcare outcomes.
- SANUWAVE Health's patented energy transfer technologies are applied in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Impact - Why it Matters
This news matters as it directly affects SANUWAVE Health, Inc. stockholders and the trading of the company's common stock. The reverse stock split will impact the number of outstanding shares and will require stockholders to exchange their shares for post-reverse split shares. It also provides important information for stockholders on the process for exchanging their shares and where to find more details about the reverse stock split.
Summary
SANUWAVE Health, Inc. will implement a 1-for-375 reverse stock split of its outstanding common stock on October 18, 2024. The reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 1,181,272,961 shares to approximately 3,150,062 shares. Proportional adjustments will be made to the number of shares of SANUWAVE’s common stock subject to outstanding equity awards, convertible notes, and warrants, as well as the applicable conversion or exercise price.
Record holders of Company common stock will receive a transaction statement with respect to the exchange of such shares for post-reverse split shares. Stockholders holding stock certificates will receive information from Securities Transfer Corporation (“STC”), the transfer agent for the Company’s common stock, regarding the process for exchanging their shares of common stock. STC will act as the exchange agent for the reverse stock split and may be contacted at (469) 633-0101.
For more information on the reverse stock split, please refer to the Company’s 2024 Consent Solicitation Statement, which can be accessed through the investor portion of the Company’s website at https://sanuwave.com/investors/ and on the Securities and Exchange Commission’s (“SEC”) EDGAR website, https://www.sec.gov/.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, SANUWAVE Health, Inc. Announces Implementation of 1-for-375 Reverse Stock Split
